DataMeds AI, Inc. Common Stock vs. ZeroStack Corp. Common Stock
DataMeds AI, Inc. Common Stock and ZeroStack Corp. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| MEDS | ZSTK | |
|---|---|---|
| Market Cap | $18.59 million | $90.46 million |
| Revenue (TTM) | $813,455 | — |
| Net Income (TTM) | $-37,952,329 | — |
ZSTK leads on 1 of 1 size & scale factors.
Valuation
| MEDS | ZSTK | |
|---|---|---|
| Price / Book | 0.29 | — |
| Price / Sales | 22.85 | — |
MEDS and ZSTK split the valuation factors evenly.
Profitability
| MEDS | ZSTK | |
|---|---|---|
| Net Margin | -4665.57% | — |
| Return on Equity | -59.21% | — |
MEDS and ZSTK split the profitability factors evenly.
Risk & Sentiment
| MEDS | ZSTK | |
|---|---|---|
| Short Interest | 0.02% | 0.60% |
MEDS leads on 1 of 1 risk & sentiment factors.
Dig deeper: MEDS overview, MEDS financials, ZSTK overview, ZSTK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.